Company Filing History:
1 out of 16,338 
1 out of 106 Years Active: 1999-2000
Title: The Innovations of Daniel Emmett Duffy
Introduction
Daniel Emmett Duffy is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 2 patents, his work has implications in medical science, specifically in the area of thrombin and factor Xa inhibition.
Latest Patents
Duffy's latest patents focus on amidinoindoles, amidinoazoles, and their analogs. The first patent describes these compounds of formula I, where W, W¹, W², and W³ are selected from CH and N. It specifies that one of W¹ and W² is C(C(═NH)NH₂) and at most two of W, W¹, W², and W³ are N. Additionally, one of Jᵃ and Jᵇ is substituted by --(CH₂)ₙ--Z--A--B, which are useful as inhibitors of factor Xa or thrombin. The second patent presents similar compounds with the same structural characteristics and potential applications.
Career Highlights
Throughout his career, Duffy has worked with prominent companies such as E.I. du Pont de Nemours and Company and DuPont Pharmaceuticals Company. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in his field.
Collaborations
Duffy has collaborated with talented individuals, including Celia Dominguez and Qi Han. These partnerships have likely enriched his research and development efforts.
Conclusion
Daniel Emmett Duffy's innovative work in the field of chemistry, particularly with amidinoindoles and amidinoazoles, showcases his dedication to advancing medical science. His patents reflect a commitment to developing compounds that could have a substantial impact on healthcare.